Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1593286 | 0.90 | TSHR (0.50) | TSHRSIGMAR1LMNAADRA2BHTR2A | |
| Hydrochloric Acid SCHEMBL16447410 | 0.88 | TSHR (0.48) | TSHRSIGMAR1LMNAADRA2BHTR2A | |
| SCHEMBL3403185 | 0.85 | BCHE (0.49) | TSHRSIGMAR1LMNABCHEADRA2B | |
| SCHEMBL8757082 | 0.84 | TSHR (0.46) | TSHRSIGMAR1LMNAADRA2BHTR2A | |
| SCHEMBL12124877 | 0.83 | TSHR (0.50) | TSHRSIGMAR1CNR2LMNABCHE | |
| SCHEMBL9380682 | 0.82 | LMNA (0.46) | TSHRSIGMAR1CNR2LMNABCHE | |
| SCHEMBL9816880 | 0.81 | BCHE (0.51) | TSHRSIGMAR1LMNABCHEADRA2B | |
| (Chloromethyl)Benzene SCHEMBL124016 | 0.81 | TSHR (0.49) | TSHRSIGMAR1LMNAADRA2BHTR2A | |
| SCHEMBL9816883 | 0.81 | BCHE (0.51) | TSHRSIGMAR1LMNABCHEADRA2B | |
| SCHEMBL454605 | 0.81 | LMNA (0.49) | TSHRSIGMAR1CNR2LMNABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754859-A | Amine-containing thioxanthone polyurethane modified epoxy acrylate LED photocuring resin | 明光科迪新材料有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113736092-A | Hyperbranched LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-113717370-A | 2 nd-generation hyperbranched LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-11-30 | — | — | CN | claimed |
| CN-113717393-A | 3 rd generation dendritic LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-11-30 | — | — | CN | claimed |
| US-12258316-B2 | Biphenyl compounds useful as muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2025-03-25 | — | — | US | disclosed |
| US-20220306579-A1 | BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-09-29 | — | — | US | disclosed |
| US-11247969-B2 | Biphenyl compounds useful as muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2022-02-15 | — | — | US | disclosed |
| CN-113754859-A | Amine-containing thioxanthone polyurethane modified epoxy acrylate LED photocuring resin | 明光科迪新材料有限公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-113736092-A | Hyperbranched LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-12-03 | — | — | CN | disclosed |
| CN-113717370-A | 2 nd-generation hyperbranched LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-113717393-A | 3 rd generation dendritic LED resin modified by amine-containing thioxanthone photoinitiating group | 吉力水性新材料科技（珠海）有限公司 | 2021-11-30 | — | — | CN | disclosed |
| US-20200290966-A1 | BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2020-09-17 | — | — | US | disclosed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | disclosed |
| US-4935413-A | ELASTICITY, ADHESION AND DISPERSIBILITY | NIPPON PAINT CO., LTD. (JP) | 1990-06-19 | — | — | US | disclosed |
| US-4902727-A | Compounds having a polymerizable acylurethane structure, and their production and process of using | NIPPON PAINT CO., LTD. (JP) | 1990-02-20 | — | — | US | disclosed |
| EP-0204497-A1 | Polymerisation process employing compounds having polymerisable acylurethane structures | Nippon Paint Co., Ltd. (JP) | 1986-12-10 | — | — | EP | disclosed |
| EP-0177122-A2 | Acrylamide derivatives | Nippon Paint Co., Ltd. (JP) | 1986-04-09 | — | — | EP | disclosed |
| US-4110286-A | Stable polyurethane latices, emulsifiable prepolymers therefor and methods of making the same | ALCOLAC INC. (US) | 1978-08-29 | — | — | US | disclosed |
| US-4063887-A | HYDROXYAMINE COMPOUND | CELANESE CORPORATION (US) | 1977-12-20 | — | — | US | disclosed |
| US-4009201-A | PARTIALLY OR FULLY QUATERNIZED POLYAMINE ESTERS OF ACRYLIC ACIDS | ALCOLAC INC. (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11247969-B2 | Biphenyl compounds useful as muscarinic receptor antagonists | CHRM2, CHRM1, CHRM3 | TSHR 68/4885SIGMAR1 374/4885CNR2 49/4885 |
| US-20220306579-A1 | BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | CHRM2, CHRM1, CHRM3 | TSHR 68/4885SIGMAR1 374/4885CNR2 49/4885 |
| US-12258316-B2 | Biphenyl compounds useful as muscarinic receptor antagonists | CHRM2, CHRM1, CHRM3 | TSHR 68/4885SIGMAR1 374/4885CNR2 49/4885 |
| US-20200290966-A1 | BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | CHRM2, CHRM1, CHRM3 | TSHR 68/4885SIGMAR1 374/4885CNR2 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.